HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.

AbstractBACKGROUND:
Cathepsin B has been shown to play an important role in invasion and metastasis of prostate cancer. The objective of this study was to determine whether serum levels of cathepsin B and its density (cathepsin B-D) could be used as predictors of disease extension as well as prognosis in patients with prostate cancer.
MATERIALS AND METHODS:
Serum levels of cathepsin B in 60 healthy controls, 80 patients with benign prostatic hypertrophy (BPH) and 120 patients with prostate cancer were measured by a sandwich enzyme immunoassay. Cathepsin B-D was calculated by dividing the serum levels of cathepsin B by the prostate volume, which was measured using transrectal ultrasonography. We subsequently analyzed the association between these two factors and several clinicopathological factors.
RESULTS:
The mean values of cathepsin B and cathepsin B-D in patients with prostate cancer were significantly higher than those in healthy controls and BPH patients. Moreover, the cathepsin B and cathepsin B-D levels in patients with metastasis were significantly elevated compared with those in patients without metastasis. Among patients undergoing radical prostatectomy, the levels of cathepsin B and cathepsin B-D in those with pathologically confirmed extraprostatic disease were significantly higher than in patients with organ-confined disease. However, there was no significant association between the elevation of cathepsin B and cathepsin B-D levels and cause-specific survival in prostate cancer patients.
CONCLUSION:
These findings indicate that the elevation of serum cathepsin B and cathepsin B-D could be used as novel predictors of disease extension, but not survival, in patients with prostate cancer.
AuthorsHideaki Miyake, Isao Hara, Hiroshi Eto
JournalAnticancer research (Anticancer Res) 2004 Jul-Aug Vol. 24 Issue 4 Pg. 2573-7 ISSN: 0250-7005 [Print] Greece
PMID15330217 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Cathepsin B
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (blood)
  • Case-Control Studies
  • Cathepsin B (blood)
  • Disease Progression
  • Humans
  • Male
  • Middle Aged
  • Prostatic Hyperplasia (enzymology, pathology)
  • Prostatic Neoplasms (enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: